Genfit S.A. (EPA:GNFT)
4.650
-0.200 (-4.12%)
At close: Dec 5, 2025
Genfit Employees
Genfit had 180 employees as of December 31, 2024. The number of employees increased by 21 or 13.21% compared to the previous year.
Employees
180
Change (1Y)
21
Growth (1Y)
13.21%
Revenue / Employee
€240,027
Profits / Employee
€206,170
Market Cap
231.55M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| Sanofi | 82,878 |
| Sartorius Stedim Biotech | 9,901 |
| bioMérieux | 14,754 |
| Eurofins Scientific SE | 62,696 |
| Ipsen | 5,358 |
| ABIVAX Société Anonyme | 69 |
| Virbac | 6,365 |
Genfit News
- 8 days ago - Genfit Appoints Pejvack Motlagh As Chief Medical Officer - Nasdaq
- 8 days ago - GENFIT Announces Appointment of new Chief Medical Officer - GlobeNewsWire
- 15 days ago - GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate Update - GlobeNewsWire
- 15 days ago - GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market - GlobeNewsWire
- 26 days ago - GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF - GlobeNewsWire
- 26 days ago - GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025 - GlobeNewsWire
- 5 weeks ago - Genfit (GNFT) Plans to Voluntarily Delist from Nasdaq - GuruFocus
- 5 weeks ago - GENFIT to delist American depositary shares from Nasdaq - Seeking Alpha